Depressie en cognitie bij type 2 diabetes. Miranda Schram afdeling Interne Geneeskunde MUMC+

Size: px
Start display at page:

Download "Depressie en cognitie bij type 2 diabetes. Miranda Schram afdeling Interne Geneeskunde MUMC+"

Transcription

1 Depressie en cognitie bij type 2 diabetes Miranda Schram afdeling Interne Geneeskunde MUMC+

2 Disclosure potential conflicts of interest Geen (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties: Bedrijfsnamen Sponsoring of onderzoeksgeld - Honorarium of andere (financiële) vergoeding - Aandeelhouder - Andere relatie, namelijk -

3 Eén derde van de volwassen Limburgers heeft (pre)diabetes 2 van 6 vakken met publiek

4 Type 2 diabetes and depression Risk of depression in type 2 diabetes is doubled QoL, societal costs Mortality risk : OR for mortality 1.46 * OR for cvd mortality 1.39 * * F. van Dooren et al, Plos One 2013; 8(3):e57058

5 Course of depression in type 2 diabetes

6 Course of depression in type 2 diabetes Paucity of data Probably a chronic course Under reported, under recognised, under treatment Treatment resistance, ineffective treatment? Different etiology than early life depression Biology largely unknown

7 Mechanisms Psychosocial variables Lifestyle factors Biological mechanisms

8 Mechanisms Psychosocial variables Lifestyle factors Biological mechanisms

9 Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

10 Research questions We investigated the associations between markers of - Hyperglycemia (glucose, AGEs) - Inflammation, and - Endothelial dysfunction with depressive symptoms and depressive disorder in a population-based study

11 Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

12 The Maastricht Study 10,000 participants, years From the Maastricht area Oversampling of type 2 diabetes Advanced deep phenotyping Survey I: Dataset n~3400 (Nov 10-Sept 13) Eur J Epidemiology (2014) 29:

13 Extremely detailed phenotyping

14 Depression PHQ-9, MINI diagnostic interview (gold standard) Diabetes Oral glucose tolerance test Methods Glycemic control (fasting gluc, HbA1c, AGEs: SAF, Pentosidine, CEL, CML) Inflammation (hscrp, SAA, sicam-1, IL-6, IL-8, TNF-α) Endothelial function (svcam-1, sicam-1, se-selectin, vwf) MRI (brain atrophy and cerebral small vessel disease) Lifestyle (physical activity, sedentary time, nutrition)

15 General characteristics No type 2 diabetes (n=2349) Type 2 diabetes (n=918) Age, years 58.7 ± ± 7.6 Female sex, n (%) 1291 (55%) 298 (33%) Partner, n (%) 1972 (85%) 731 (82%) Educational level, % low/middle/high 28/28/44 46/28/26 HbA1c, % 5.5 ± ± 1.0 Smoking, % never/former/current 37/50/12 28/56/16 Body mass index, kg/m ± ± 5.0 Blood pressure, mmhg 132 ± 17 / 76 ± ± 18 / 77 ± 10 Total cholesterol, mmol/l 5.5 ± ± 1.0 HDL cholesterol, mmol/l 1.61 ± ± 0.37 N= 3267

16 Prevalence of depression prevalence in % ,4 * 6,2 * 2,7 2,7 * 6,3 4,0 * 9,0 Non-DM DM ,4 PHQ-9 score > 10 Minor depression Major depression Major and minor depression

17 Association of depression with T2DM Depressive symptoms Odds ratio 95% CI p-value PHQ-9 score (continuous) 1.06 ( ) < PHQ ( ) Depressive disorder Minor depressive disorder (MINI) 1.81 ( ) Major depressive disorder (MINI) 1.99 ( ) Adjusted for age, sex, educational level, bmi, smoking, partner status, systolic blood pressure, prior CVD, total cholesterol and HDL cholesterol

18 Hyperglycemia and depression Independent variables Fasting glucose per SD HbA1c per SD Skin Autofluoresence per SD Hyperglycemia sum score per SD Major depression OR (95%CI) P-value 1.30 ( ) ( ) ( ) ( ) <0.001 adjusted for age, sex, smoking, alcohol consumption, hypertension, cholesterol ratio, physical activity, and BMI

19 Advanced Glycation Endproducts (AGEs) * Adjusted for age, sex, type 2 diabetes, bmi, smoking, egfr Van Dooren et al, Depression and Anxiety, 2016 Jun 6

20 Insuline resistance and depression Independent variables Major depression OR (95%CI) P-value Fasting insulin per SD HOMA per SD Insulin resistance markers sum score per SD 0.97 ( ) ( ) ( ) adjusted for age, sex, smoking, alcohol consumption, hypertension, cholesterol ratio, physical activity, and BMI

21 Hyperglycemia, IR and depression

22 Conclusie Type 2 diabetes is geassocieerd met meer depressie Verschillende maten van hyperglycemie zijn geassocieerd met depressie Insuline resistentie is niet geassocieerd met depressie

23 Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

24 Depression PHQ-9, MINI diagnostic interview (gold standard) Diabetes Oral glucose tolerance test Methods Glycemic control (fasting gluc, HbA1c, AGEs: SAF, Pentosidine, CEL, CML) Inflammation (hscrp, SAA, sicam-1, IL-6, IL-8, TNF-α) Endothelial function (svcam-1, sicam-1, se-selectin, vwf) MRI (brain atrophy and cerebral small vessel disease) Lifestyle (physical activity, sedentary time, nutrition)

25 Low grade inflammation * * * * * OR was 1,54 (1,18-2,02) for LGI sumscore after adjustment for age, sex, DM2, egfr, prior CVD Van Dooren et al, Brain Behaviour and Immunity, 2016 Aug;56:390-6.

26 Endothelial dysfunction Odds ratio 1,8 1,7 1,6 1,5 1,4 1,3 1,2 1,1 1 Endothelial function is associated with depressive disorder * 1,25 * * 1,35 1,36 1,19 1,64 svcam-1 sicam-1 E-selectine vwf ED sumscore * OR was 1,40 (1,10-1,77) for ED sumscore after adjustment for age, sex, DM2, egfr, prior CVD Van Dooren et al, Brain Behaviour and Immunity, 2016 Aug;56:390-6.

27 Inflammation and incident depression Longitudinal associations of low-grade inflammation sum score with incident depression Odds ratio 95% CI p value Model 1: crude + demographics <0.001 Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

28 Endothelial dysfunction and incident depression Longitudinal associations of endothelial dysfunction sum score with incident depression Odds ratio 95% CI p value Model 1: crude + demographics <0.001 Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

29 LGI, ED and incident depression 55% 45%

30 Inflammation, endothelial dysfunction and chronic depression Remission Resistant or recurrent LGI Odds ratio 95% CI p value Odds ratio 95% CI p value Model 1: demographics ; ; Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors ; ; ; ; ED Model 1: demographics ; ; Model 2: model 1 + cardiovascular risk factors Model 3: model 2 + lifestyle risk factors ; ; ; ; Model 1 included age, sex, education status and partner status; model 2 additionally incorporated cardiovascular risk factors as type 2 diabetes status, history of cardiovascular disorder, kidney function and HbA1c; model 3 added modifiable lifestyle risk factors as body mass index (BMI), blood pressure, smoking and physical activity.

31 Depressie als gevolg van vaatschade ORs = Agtmaal et al JAMA Psychiatry 2017 Jul 1;74(7):

32 Conclusie Inflammatie en endotheel dysfunctie zijn geassocieerd met incidente depressie, mogelijk causaal verband Inflammatie en endotheel dysfunctie samen kunnen chronische depressie voorspellen

33 Mechanisms Psychosocial variables Inflammation Lifestyle factors Biological mechanisms Endothelial dysfunction

34 Type 2 diabetes and dementia 2x greater risk of dementia in type 2 diabetes Via hyperglycaemia? Via vascular brain damage?

35 Type 2 diabetes and cognitieve functie

36 White matter hyperintensities

37 Brain tissue volumes

38 Vaatschade in het brein Vaatschade op MRI Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

39 White matter volume Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

40 Grey matter volume Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

41 Cerebrospinal fluid Geen diabetes Pre-diabetes Diabetes Van Agtmaal et al, submitted

42 Conclusion Prediabetes is associated with White matter hyperintensities Lower white matter volume 4 years of aging T2DM is associated with White matter hyperintensities Lower white matter volume Higher CSF volume 8.5 years of aging

43 Take home message Depressie en dementie komen 2x zo veel voor bij type 2 diabetes Verklarende mechanismen hiervoor zijn: Hyperglycemie Inflammatie Endotheel dysfunctie Vasculaire brein schade Zowel prediabetes als type 2 diabetes zijn geassocieerd met versnelde veroudering van het brein weefsel vergelijkbaar met 4 vs 8 jaar veroudering

44 Eén derde van de volwassen Limburgers heeft (pre)diabetes 2 van 6 vakken met publiek

45 17 PhD theses on The Maastricht Study A further 20 PhD theses in preparation

The heat is on (and on)

The heat is on (and on) The heat is on (and on) Cornelis Kramers Internist clinical pharmacologist kees.kramers@radboudumc.nl Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante

More information

Nationaal Pijncongres Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV

Nationaal Pijncongres Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV Nationaal Pijncongres 0 Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties met bedrijven

More information

The public health benefits of vaccination: expenditures, morbidity & mortality

The public health benefits of vaccination: expenditures, morbidity & mortality The public health benefits of vaccination: expenditures, morbidity & mortality Maarten van Wijhe (RIVM / RUG) Scott McDonald (RIVM) Hester de Melker (RIVM) Maarten Postma (RUG) Jacco Wallinga (RIVM / LUMC)

More information

Hemodialysis induces an acute decline in cerebral perfusion in elderly patients

Hemodialysis induces an acute decline in cerebral perfusion in elderly patients Hemodialysis induces an acute decline in cerebral perfusion in elderly patients Casper Franssen Dept. of Nephrology University Medical Dutch Nephrology days 2019 Disclosures/ Disclosure belangen spreker

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Vitamin D supplementation of professionally active adults

Vitamin D supplementation of professionally active adults Vitamin D supplementation of professionally active adults VITAMIN D MINIMUM, MAXIMUM, OPTIMUM FRIDAY, SEPTEMBER 22 ND 2017 Samantha Kimball, PhD, MLT Research Director Pure North S Energy Foundation The

More information

Total amount and patterns of sedentary behaviour & glucose metabolism status

Total amount and patterns of sedentary behaviour & glucose metabolism status Total amount and patterns of sedentary behaviour & glucose metabolism status Julianne van der Berg PhD candidate j.vanderberg@maastrichtuniversity.nl THE PROBLEM Long periods of sedentary behaviour (sitting,

More information

STATEC. Selective Targeting of Adjuvant Therapy for Endometrial Cancer. Florine Eggink National kick-off meeting April 17th 2018

STATEC. Selective Targeting of Adjuvant Therapy for Endometrial Cancer. Florine Eggink National kick-off meeting April 17th 2018 STATEC Selective Targeting of Adjuvant Therapy for Endometrial Cancer Florine Eggink National kick-off meeting April 17th 2018 Disclosures (potentiële) belangenverstrengeling Geen Voor bijeenkomst mogelijk

More information

Luchtvervuiling en gezondheid: de mechanistische inzichten

Luchtvervuiling en gezondheid: de mechanistische inzichten SYMPOSIUM Luchtvervuiling en gezondheid: de mechanistische inzichten Dr. Ir. Frans de Jongh Longfysioloog Medisch Spectrum Twente, Enschede, the Netherlands Academic Medical Centre, Amsterdam, the Netherlands

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic

More information

Other Ways to Achieve Metabolic Control

Other Ways to Achieve Metabolic Control Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

300 Biomed Environ Sci, 2018; 31(4):

300 Biomed Environ Sci, 2018; 31(4): 300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2

Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

Opportunities and challenges for human papillomavirus vaccination in cancer prevention

Opportunities and challenges for human papillomavirus vaccination in cancer prevention Opportunities and challenges for human papillomavirus vaccination in cancer prevention Johannes A Bogaards, PhD National Institute for Public Health and the Environment, The Netherlands VU University Medical

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk Eberhard Standl European Heart House Sophia Antipolis Thursday, June 17, 2010 IDF Diabetes Atlas 2009: Global Numbers Still

More information

Informing HPV vaccination strategy about target groups: girls-only, gender-neutral, catch-up and selective adult vaccination

Informing HPV vaccination strategy about target groups: girls-only, gender-neutral, catch-up and selective adult vaccination Informing HPV vaccination strategy about target groups: girls-only, gender-neutral, catch-up and selective adult vaccination Johannes A Bogaards, PhD National Institute for Public Health and the Environment,

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:

More information

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

LUNG CANCER EARLY MOLECULAR ASSESSMENT KIM MONKHORST WEEK VAN DE PATHOLOGIE 29 MAART

LUNG CANCER EARLY MOLECULAR ASSESSMENT KIM MONKHORST WEEK VAN DE PATHOLOGIE 29 MAART LUNG CANCER EARLY MOLECULAR ASSESSMENT KIM MONKHORST WEEK VAN DE PATHOLOGIE 29 MAART Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties met bedrijven

More information

Heart and Kidney, for better or for worse

Heart and Kidney, for better or for worse Heart and Kidney, for better or for worse P. van Paassen, MD, PhD Dept. Nephrology and Clinical Immunology Maastricht UMC+ Hartfalen dag Zeist, 29 09 17 Disclosure potential conflicts of interest Geen

More information

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum Workshop Nefrologie Papendal 12 December 2018 De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum Disclosure belangen

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Macrovascular Disease in Diabetes

Macrovascular Disease in Diabetes Macrovascular Disease in Diabetes William R. Hiatt, MD Professor of Medicine/Cardiology University of Colorado School of Medicine President, CPC Clinical Research Conflicts CPC Clinical Research (University-based

More information

6/10/2016. Hui-Chun Hsu

6/10/2016. Hui-Chun Hsu Hui-Chun Hsu PhD, RN, CDE Chief, Department of Diabetes Management Lee s Endocrinology Clinic Pingtung, Taiwan Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures:

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

Diabetes Prevention. Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink.

Diabetes Prevention. Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink. Diabetes Prevention Preventing Diabetes -- On AAA Home, the hyperlink beside the LESS Initiative hyperlink. Preventing Diabetes is the extension of the LESS Initiative and should be completed as part of

More information

Intestinal Stem Cells And Organoids

Intestinal Stem Cells And Organoids Intestinal Stem Cells And Organoids Marc van de Wetering NVMO 2015 Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties met bedrijven Sponsoring

More information

Pitfalls in chemical burns

Pitfalls in chemical burns Pitfalls in chemical burns 3de Lage Landen Symposium Intoxicaties Dr. Geert Verstegen Belgian Poison Centre 26 June 2015, Ghent Disclosure belangen spreker (potentiële) belangenverstrengeling Geen / Zie

More information

Patient is healthy with no chronic disease or significant risk factors [16%].

Patient is healthy with no chronic disease or significant risk factors [16%]. AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II

More information

Standards of Medical Care In Diabetes

Standards of Medical Care In Diabetes Standards of Medical Care In Diabetes - 2017 Robert E. Ratner, MD, FACP, FACE Professor of Medicine Georgetown University School of Medicine Disclosed no conflict of interest Standards of Care Professional.diabetes.org/SOC

More information

Adolescent Bariatric Surgery

Adolescent Bariatric Surgery Adolescent Bariatric Surgery. Roundtable on Obesity Solutions - April 6, 2017 Marc Michalsky, M.D., FACS, FAAP Professor of Clinical Surgery and Pediatrics - The Ohio State University, College of Medicine

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group Establishment of Efficacy of Intervention in those with Metabolic Syndrome Dr Wendy Russell - ILSI Europe Expert Group Conflict of interest regarding this presentation: I have no conflict of interest to

More information

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y Preventing Diabetes 2018 K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y D A V I D G E F F E N S C H O O L O F M E D I C I N E A T U C L A CO-DIRECTOR,

More information

programme. The DE-PLAN follow up.

programme. The DE-PLAN follow up. What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa

More information

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes and coronary artery disease Marijan Bosevski 1, *, Golubinka Bosevska 1, Lily Stojanovska 2, Vasso Apostolopoulos 2, * 1 University

More information

Cognitive ageing and dementia: The Whitehall II Study

Cognitive ageing and dementia: The Whitehall II Study Cognitive ageing and dementia: The Whitehall II Study Archana SINGH-MANOUX NIH: R01AG013196; R01AG034454; R01AG056477 MRC: K013351, MR/R024227 BHF: RG/13/2/30098 H2020: #643576 #633666 Outline Lifecourse

More information

Cardiovascular disease and diabetes Vascular harmony

Cardiovascular disease and diabetes Vascular harmony Cardiovascular disease and diabetes 2018 Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

Energy Balance Equation

Energy Balance Equation Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study

Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford

More information

Resting Heart Rate and The Risk Of Developing Impaired Fasting Glucose and Diabetes: The Kailuan Prospective Study

Resting Heart Rate and The Risk Of Developing Impaired Fasting Glucose and Diabetes: The Kailuan Prospective Study JCD JOURNAL WATCH Resting Heart Rate and The Risk Of Developing Impaired Fasting Glucose and Diabetes: The Kailuan Prospective Study Liang Wang et al. Int. J. Epidemiol. (2015); doi: 10.1093/ije/dyv079.

More information

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of

More information

Magnetic resonance imaging, image analysis:visual scoring of white matter

Magnetic resonance imaging, image analysis:visual scoring of white matter Supplemental method ULSAM Magnetic resonance imaging, image analysis:visual scoring of white matter hyperintensities (WMHI) was performed by a neuroradiologist using a PACS system blinded of baseline data.

More information

A new look on the renal risks of lithium. Maarten B Rookmaaker

A new look on the renal risks of lithium. Maarten B Rookmaaker A new look on the renal risks of lithium Maarten B Rookmaaker Renal Highlights 2018 Disclosure belangen Maarten Rookmaaker (potentiële) Belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study 2278 Diabetes Volume 66, August 2017 Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study Nordin M.J. Hanssen,

More information

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Community Based Diabetes Prevention

Community Based Diabetes Prevention Community Based Diabetes Prevention Melanie Davies Professor of Diabetes Medicine Outline NIHR Programme Grant proposal and update to progress The Vascular Check programme HbA1c debate Algorithm to detect

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH

ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH I Jialal, MD, PhD. FRCPath.DABCC Robert E. Stowell Chair in Experimental Pathology Professor of Pathology and Medicine Director, Laboratory

More information

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis

HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis My personal objective: identification of biomarkers of (optimal) health Biomarker Definition: a characteristic that is objectively measured and evaluated

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information

Baroreflex amplificatie als behandeling voor hypertensie: hype of hoop? Wilko Spiering Afdeling Vasculaire Geneeskunde

Baroreflex amplificatie als behandeling voor hypertensie: hype of hoop? Wilko Spiering Afdeling Vasculaire Geneeskunde Baroreflex amplificatie als behandeling voor hypertensie: hype of hoop? Wilko Spiering Afdeling Vasculaire Geneeskunde Nederlands Vasculair Forum, 1 december 2017 Disclosure potential conflicts of interest

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

SMARTool clinical and biohumoral results. Chiara Caselli IFC-CNR

SMARTool clinical and biohumoral results. Chiara Caselli IFC-CNR SMARTool clinical and biohumoral results Chiara Caselli IFC-CNR SMARTool Flow chart EVINCI and ARTreat Populations SMARTool: WP1 and WP2 WP1 Objective: To collect retrospective EVINCI clinical and imaging

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

1/28/2014. The Metabolic Syndrome: Early History. Insulin Resistance: Early Diagnosis and Treatment to Prevent Cardiovascular Disease

1/28/2014. The Metabolic Syndrome: Early History. Insulin Resistance: Early Diagnosis and Treatment to Prevent Cardiovascular Disease : Early Diagnosis and Treatment to Prevent Cardiovascular Disease Henry N. Ginsberg, M.D. Irving Professor of Medicine Columbia University College of Physicans and Surgeons The Metabolic Syndrome: Early

More information

Arterial function and longevity Focus on the aorta

Arterial function and longevity Focus on the aorta Arterial function and longevity Focus on the aorta Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Secrets of longevity Secrets of longevity Unveiling

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Diabetes and Obesity Sex- and Gender-differences!

Diabetes and Obesity Sex- and Gender-differences! Oskar Kokoschka 1908 Das Mädchen Li und ich Diabetes and Obesity Sex- and Gender-differences! Alexandra Kautzky Willer IGM, Berlin 2015 Global Diabetes-Epidemic Increase (%) in age-standardised diabetes

More information

Low carbohydrate diets- do they have a place?

Low carbohydrate diets- do they have a place? Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]

More information

The Effect of Hypertonicity on Glucose Regulation in Healthy Adults

The Effect of Hypertonicity on Glucose Regulation in Healthy Adults University of Arkansas, Fayetteville ScholarWorks@UARK Biological Sciences Undergraduate Honors Theses Biological Sciences 5-2016 The Effect of Hypertonicity on Glucose Regulation in Healthy Adults Alison

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Diabetes Mellitus: Implications of New Clinical Trials and New Medications Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October

More information

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease Steve Smith, Group Director Scientific Affairs, Diabetes & Metabolism GlaxoSmithKline R & D

More information

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program

More information

surtout qui n est PAS à risque?

surtout qui n est PAS à risque? 3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular

More information

Diabetes type-2 patients can stop insulin treatment when following the low carbohydrate lifestyle

Diabetes type-2 patients can stop insulin treatment when following the low carbohydrate lifestyle Diabetes type-2 patients can stop insulin treatment when following the low carbohydrate lifestyle EFAD Congres, Rotterdam, The Netherlands November 2018 Harriet Verkoelen, Dutch dietician and Diabetes

More information

Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studies

Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studies Ptushkina et al. BMC Public Health (2018) 18:1331 https://doi.org/10.1186/s12889-018-6265-0 RESEARCH ARTICLE Open Access Regional differences of macrovascular disease in Northeast and South Germany: the

More information

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the

More information

Diabetic Retinopathy: a case study David Garland NP

Diabetic Retinopathy: a case study David Garland NP Diabetic Retinopathy: a case study David Garland NP Financial disclosure With 3 daughters I don t have any finances The patient Joe 45 year old Polynesian man with hx of diabetic retinopathy Routine f/up

More information

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013

More information

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information